deltatrials
Completed PHASE3 NCT00000512

Familial Atherosclerosis Treatment Study

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Cardiovascular Diseases Coronary Arteriosclerosis Coronary Disease Heart Diseases Myocardial Ischemia
Interventions Placebo for colestipol Placebo for lovastatin colestipol lovastatin niacin
Updated 6 times since 2017 Last updated: Dec 1, 2015 Started: Jan 31, 1984 Primary completion: Aug 31, 1989 Completion: Aug 31, 1989

Listed as NCT00000512, this PHASE3 trial focuses on Cardiovascular Diseases and Coronary Arteriosclerosis and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 6 times since 1984, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Jan 1984

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of Washington
Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.